These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9635386)

  • 21. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control.
    Cucinotta D; Mannino D; Lasco A; Di Cesare E; Musolino C; Alessi R
    Diabete Metab; 1991; 17(1):49-54. PubMed ID: 1868960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of insulin pen devices.
    McCoy EK; Wright BM
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New methods in insulin treatment].
    Neuwirth G
    Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin pumps and their use in pregnancy.
    Wollitzer AD; Zisser H; Jovanovic L
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S33-6. PubMed ID: 20515304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential for the use of insulin lispro in pregnancy complicated by diabetes.
    Carr KJ; Lindow SW; Masson EA
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):323-9. PubMed ID: 16801307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome.
    Langer O; Yogev Y; Xenakis EM; Rosenn B
    Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin pens: the modern delivery devices.
    Baruah MP
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients.
    Dunbar JM; Madden PM; Gleeson DT; Fiad TM; McKenna TJ
    Diabetes Care; 1994 Aug; 17(8):874-8. PubMed ID: 7956634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perinatal outcomes in pregnant women with diabetes mellitus and different level of autoantibodies to insulin and its receptors].
    Protsenko AM; Budykina TS; Morozov SG; Rybakov AS; Gribova IE; Protsenko AN
    Patol Fiziol Eksp Ter; 2010; (2):18-22. PubMed ID: 20804070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The evaluation of the use of DEAE-dextran in glycemic control in diabetic patients in pregnancy].
    Valente M; Bazzoffi R; Critelli C; D'Angelo R; Evangelista E; Zichella L
    Clin Ter; 1996 Nov; 147(11):571-4. PubMed ID: 9264911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin management of type I and type II diabetes in pregnancy.
    Hare JW
    Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New technologies for the management of pregestational diabetes mellitus.
    Lee-Parritz A
    Obstet Gynecol Surv; 2012 Mar; 67(3):167-75. PubMed ID: 22901950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy in a young diabetic.
    Coustan DR
    Hosp Pract (Off Ed); 1989 Oct; 24(10A):75-8, 81-4, 87-8. PubMed ID: 2509494
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin pump therapy for pregnancy: a primer.
    Bernasko J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):552-7. PubMed ID: 22092002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.